OBELIS
Desconocido
INNO4COV-19: Boosting Innovation for COVID 19 Diagnostic Prevention and Surveillance.
OBELIS SA
participó en un
H2020:
H2020-SC1-PHE-CORONAVIRUS-2020-2
The novel corona virus causing COVID-19 overwhelmed Europe and the world in just a few weeks’ time. Small and Medium-sized Entrerprises (SME...
2020-10-13 - 2022-11-30 | Financiado
2020-10-13 - 2022-11-30 | Financiado
HypoSens: Nano confined photonic system for detection of breast cancer spread to the lymph nodes
OBELIS SA
participó en un
H2020:
H2020-ICT-2016-2017
The Vision of HypoSens is to develop a widely accepted,non-invasive and crucial prognostic tool for breast cancer progression in early stage...
2016-10-26 - 2019-10-31 | Financiado
2016-10-26 - 2019-10-31 | Financiado
GLAM: Laser Multiplexed Biosensor
OBELIS SA
participó en un
H2020:
H2020-PHC-2014-2015
Differential cancer diagnosis takes place daily in clinical settings for a better monitoring of patient responses to existing treatments. Ho...
2015-04-08 - 2019-04-30 | Financiado
2015-04-08 - 2019-04-30 | Financiado
NeuroGraft: Development of Functionalised Cell Seeded Bioartificial Organ for Transplantation in Nerve Repair
OBELIS SA
participó en un
FP7:
Injuries and degenerative diseases of the central nervous system constitute a bottleneck in medical and surgical practice for which no thera...
Financiado
Financiado
* No se disponen de datos de la empresa actual.